Theresa A Laguna1, Cynthia B Williams2, Kyle R Brandy2, Cole Welchlin-Bradford2, Catherine E Moen2, Cavan S Reilly3, Christine H Wendt4. 1. Minnesota CF Center, Department of Pediatrics, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States. Electronic address: lagun005@umn.edu. 2. Minnesota CF Center, Department of Pediatrics, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States. 3. School of Public Health, Division of Biostatistics, University of Minnesota, Minneapolis, MN, United States. 4. Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Minnesota and Veterans Administration Medical Center, Minneapolis, MN, United States.
Abstract
BACKGROUND: Cystic fibrosis (CF) patients exhibit a progressive decline in lung function accelerated by intermittent pulmonary exacerbations. There are urgent needs for clinically relevant biomarkers to aid in the diagnosis and management of a CF pulmonary exacerbation, in addition to providing insight into its pathophysiology. Club cell secretory protein (CCSP) is produced by bronchial epithelial cells, known to have anti-inflammatory properties and may play a role in CF pulmonary exacerbations. Our objective was to measure sputum CCSP concentration during hospitalizations for CF pulmonary exacerbation and during quarterly outpatient clinic visits for 2 years. We explored the correlations between CCSP concentration, lung function and markers of inflammation and infection. METHODS: In this prospective, longitudinal cohort study, expectorated sputum, blood and lung function data were collected from 45 CF patients during 68 hospitalizations for pulmonary exacerbation and 193 clinic visits. Sputum CCSP concentration was measured and sputum and blood were assayed with a panel of inflammatory cytokines. We used a repeated measures model to compare log transformed sputum CCSP concentrations across multiple time points and to correlate those concentrations with related clinical variables. RESULTS: Our population had a mean age of 29 (16-58 years), and a median FEV(1) %predicted of 60% (18-105%). Sputum CCSP concentration was significantly lower in the initial, interim and final exacerbation samples (p=0.0021, p=0.0005 and p=0.0274, respectively) compared to outpatient visits. Sputum CCSP concentration was negatively associated with sputum neutrophil elastase concentration (p=0.0373). Patients with Pseudomonas aeruginosa mucoid had a significantly lower sputum CCSP concentration (p=0.0129). CONCLUSION: Sputum CCSP concentration is associated with CF pulmonary exacerbation.
BACKGROUND:Cystic fibrosis (CF) patients exhibit a progressive decline in lung function accelerated by intermittent pulmonary exacerbations. There are urgent needs for clinically relevant biomarkers to aid in the diagnosis and management of a CF pulmonary exacerbation, in addition to providing insight into its pathophysiology. Club cell secretory protein (CCSP) is produced by bronchial epithelial cells, known to have anti-inflammatory properties and may play a role in CF pulmonary exacerbations. Our objective was to measure sputum CCSP concentration during hospitalizations for CF pulmonary exacerbation and during quarterly outpatient clinic visits for 2 years. We explored the correlations between CCSP concentration, lung function and markers of inflammation and infection. METHODS: In this prospective, longitudinal cohort study, expectorated sputum, blood and lung function data were collected from 45 CFpatients during 68 hospitalizations for pulmonary exacerbation and 193 clinic visits. Sputum CCSP concentration was measured and sputum and blood were assayed with a panel of inflammatory cytokines. We used a repeated measures model to compare log transformed sputum CCSP concentrations across multiple time points and to correlate those concentrations with related clinical variables. RESULTS: Our population had a mean age of 29 (16-58 years), and a median FEV(1) %predicted of 60% (18-105%). Sputum CCSP concentration was significantly lower in the initial, interim and final exacerbation samples (p=0.0021, p=0.0005 and p=0.0274, respectively) compared to outpatient visits. Sputum CCSP concentration was negatively associated with sputum neutrophil elastase concentration (p=0.0373). Patients with Pseudomonas aeruginosa mucoid had a significantly lower sputum CCSP concentration (p=0.0129). CONCLUSION: Sputum CCSP concentration is associated with CF pulmonary exacerbation.
Authors: P L Ramsay; F J DeMayo; S E Hegemier; M E Wearden; C V Smith; S E Welty Journal: Am J Respir Crit Care Med Date: 2001-07-01 Impact factor: 21.405
Authors: N Shijubo; Y Itoh; T Yamaguchi; Y Shibuya; Y Morita; M Hirasawa; R Okutani; T Kawai; S Abe Journal: Eur Respir J Date: 1997-05 Impact factor: 16.671
Authors: A Bernard; H Roels; R Lauwerys; R Witters; C Gielens; A Soumillion; J Van Damme; M De Ley Journal: Clin Chim Acta Date: 1992-05-15 Impact factor: 3.786
Authors: Nicole P Malvin; Justin T Kern; Ta-Chiang Liu; Steven L Brody; Thaddeus S Stappenbeck Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-05-22 Impact factor: 5.464
Authors: Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto Journal: Eur Respir J Date: 2021-11-11 Impact factor: 33.795
Authors: Theresa A Laguna; Cynthia B Williams; Myra G Nunez; Cole Welchlin-Bradford; Catherine E Moen; Cavan S Reilly; Chris H Wendt Journal: Respir Res Date: 2018-01-08
Authors: Zhihong Zhang; Jin Wang; Yanhui H Zhang; Tonia E Gardner; Elizabeth A Fitzpatrick; Weiqiang Zhang Journal: Int J Mol Sci Date: 2021-03-05 Impact factor: 5.923